Published in Hematology Am Soc Hematol Educ Program on January 01, 2011
MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. PLoS One (2013) 0.88
Brentuximab Vedotin in CD30+ Lymphomas. Biol Ther (2013) 0.77
Primary pediatric cardiac malignancies: the SEER experience. Pediatr Surg Int (2013) 0.76
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma. Cancer Med (2016) 0.76